NIH-funded research R21 grant

Exploring genetic changes that may help increase lifespan

Official title: Genome engineering for a novel post-reproductive genetic screen for increased longevity

Funded at University of Oregon · NIH-11078251 · Data updated 2026-11-12

This study is looking at how certain genetic changes might help people live longer, especially older adults, by using a new method to explore these changes in a lab setting.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Oregon
NIH-funded
Lab location1 site (Eugene, United States)
Project startMay 1, 2024
Project endFebruary 28, 2026
Funding year2025
Award (this year)$186,250
NIH project number5R21AG086869-02
Project IDNIH-11078251 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are individuals aged 65 and older who are interested in advancements related to aging and longevity.

Less likely to help

Patients under the age of 65 or those with conditions that significantly impair their ability to participate in genetic studies may not benefit from this research.

What this research studies

This research investigates how specific genetic mutations can influence longevity, particularly in older adults. By utilizing a novel genetic engineering technique called TARDIS, the study aims to identify and propagate mutations that could lead to increased lifespan in a model organism. The approach involves creating a system that allows for targeted changes in the genome, which can then be analyzed for their effects on longevity. This could provide insights into the genetic factors that contribute to aging and longevity.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding how to promote longer, healthier lives.

How similar studies have gone: Previous research has successfully identified mutations associated with increased longevity, but this approach using TARDIS for targeted mutagenesis is relatively novel.

Where this research is happening

  • University of Oregon
    Eugene, United States
    Active

Researchers

  • Principal investigator: Phillips, Patrick C. — University of Oregon
  • Study coordinator: Phillips, Patrick C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.